We don't just invest in entrepreneurs. We partner with them.
Since 1980 Atlas Venture has invested at the earliest stages in technology and life sciences innovation. We've helped build more than 350 companies in 16 countries; and taken more than 50 companies public.
We partner with the entrepreneurs that challenge conventional thinking and solve the hard problems. We invest in innovation that has the potential to change the structure of markets. We value businesses that define agility, scalability and defensibility.
|
“Our company developed from a start-up to a successful public company with over 500 employees and $80 million in annual revenues by following a bold, innovative strategy. This strategy was developed with valuable insight from Atlas Venture, and key to the strategy was a major contract with Glaxo SmithKline, which was facilitated by Atlas' contacts there.”
George Scangos Ph.D., President and CEOExelixis |